STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Revenue from license agreement	$ 7,000
Research and development	117,995	$ 103,393
General and administrative	28,719	28,884
Total operating expenses	146,714	132,277
Loss from operations	(139,714)	(132,277)
Other income, net	12,541	10,445
Net loss	$ (127,173)	$ (121,832)
Per share information:
Net loss per share of common stock, basic	$ (1.68)	$ (2.02)
Net loss per share of common stock, diluted	$ (1.68)	$ (2.02)
Weighted average common shares outstanding, basic	75,805,840	60,357,052
Weighted average common shares outstanding diluted	75,805,840	60,357,052
Comprehensive loss
Net Income (Loss)	$ (127,173)	$ (121,832)
Unrealized (loss) gain on marketable securities, net of tax	(188)	1,915
Comprehensive loss	$ (127,361)	$ (119,917)